Prevalence of major cardiovascular risk factors and adverse risk profiles among three ethnic groups in the Xinjiang Uygur Autonomous Region, China

Lipids in Health and Disease

You Chen¹  Zi-xiang Yu¹  Bang-dang Chen²  Fen Liu²  Xiang Ma¹  Zhen-Yan Fu¹  Xiao-mei Li¹  Yi-ning Yang¹  Xiang Xie¹  Yang Xiang¹  Yi-tong Ma¹  Jing Tao¹ 

[1] Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, P.R. China;Xinjiang Key Laboratory of Cardiovascular Disease Research, Urumqi 830054, P.R. China

关键词: Epidemiology;    Ethnicity;    Disparities;    Risk factors;    Cardiovascular disease;   

Others  :  815334
DOI  :  10.1186/1476-511X-12-185

 received in 2013-10-23, accepted in 2013-12-11,  发布年份 2013

【 摘 要 】

Background

Prevalence of cardiovascular disease (CVD) risk factors have been scarcely studied in Xinjiang, a multi-ethnic region.

Methods

Multi-ethnic, cross-sectional cardiovascular risk survey study in Xinjiang, including individuals of Uygur (n = 4695), Han (n = 3717) and Kazakh (n = 3196) ethnicities, aged 35-74 years. Analyses involved 11,608 participants with complete data enrolled between October 2007 and March 2010.

Results

There were differences in age-standardized prevalence of CVD risk factors between the three groups (all P < 0.001). Hypertension, obesity and smoking rates were higher among Kazakh (54.6%, 24.5%, and 35.8%, respectively). Dyslipidemia prevalence was higher among Uygur (54.3%), and diabetes prevalence was higher among Hans (7.1%). Age-standardized prevalence of adverse CVD risk profiles was different across different ethnicities. Compared with the Han participants, the Uygur and Kazakh had more CVD risk factors (P < 0.001). Compared with the Han participants, the adjusted odds ratios of 1, 2, and ≥3 risk factors profiles for Kazakh and Uygur participants were higher (all P < 0.001).

Conclusions

The present study showed the pervasive burden of CVD risk factors in all participant groups in the Xinjiang region. Three major ethnic groups living in Xinjiang had striking differences in the prevalence of major CVD risk factors and adverse risk profiles. Ethnic-specific strategies should be developed to prevent CVD in different ethnic groups, as well as to develop strategies to prevent future development of adverse CVD risk factors at a younger age.

【 授权许可】

   
2013 Tao et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]World Health Organization: World health report 2003—shaping the future. Geneva, Switzerland: World Health Organization; 2003.
• [2]Liu J, Hong Y, Wu Z, et al.: Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese multi-provincial cohort study. JAMA 2004, 291:2591-2599.
• [3]Murray L: The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. 1st edition. Cambridge, Mass: Harvard University Press; 1996.
• [4]World Health Organization: World health statistics annual. Geneva, Switzerland: World Health Organization; 1996.
• [5]Chiu M, Austin PC, Manuel DG, Tu JV: Comparison of cardiovascular risk profiles among ethnic groups using population health surveys between 1996 and 2007. CMAJ 2010, 182:E301-E310.
• [6]Sharma S, Malarcher AM, Giles WH, Myers G: Racial, ethnic and socioeconomic disparities in the clustering of cardiovascular disease risk factors. Ethn Dis 2004, 14:43-48.
• [7]Xie X, Ma Y-T, Yang Y-N, et al.: Alcohol consumption and ankle-to-brachial index: results from the cardiovascular risk survey. PLoS One 2010, 5:e15181.
• [8]Xie X, Ma YT, Yang YN, et al.: Polymorphisms in the SAA1 gene are associated with ankle-to-brachial index in Han Chinese healthy subjects. Blood Press 2011, 20:232-238.
• [9]Pan S, Yu Z-X, Ma Y-T, et al.: Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among uighur adults in Xinjiang. PLoS One 2013, 8(11):e80185.
• [10]Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497.
• [11]Chobanian AV, Bakris GL, Black HR: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289(19):2560-2572.
• [12]Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report [NIH Publication No. 98-4083]. National Heart, Lung, and Blood Institute; http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf webcite. Accessed October 11, 2012
• [13]American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(1):62-69.
• [14]Bild DE, Bluemke DA, Burke GL, et al.: Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002, 156:871-881.
• [15]Jha AK, Varosy PD, Kanaya AM, et al.: Differences in medical care and disease outcomes among black and white women with heart disease. Circulation 2003, 108:1089-1094.
• [16]Mak KH, Chia KS, Kark JD, et al.: Ethnic differences in acute myocardial infarction in Singapore. Eur Heart J 2003, 24:151-160.
• [17]Martha L, Talavera A, Larissa M, et al.: Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA 2012, 308(17):1768-1804.
• [18]Priyanka RG, Salam K, Huidrom SS, et al.: Differences in conventional caediovascular risk factors in two ethnic groups in India. Ethn Dis 2012, 6(22):372-376.
• [19]Zhai FY, He YN, Wang ZH, Hu YS: Status and characteristic of dietary intake of 12 minority nationalities in China. J Hygiene Res 2007, 36(5):539-541.
• [20]Wen B, Li H, Lu D, Song X, et al.: Genetic evidence supports demic diffusion of Han culture. Nature 2004, 431:302-305.
• [21]Xiao FX, Yang JF, Cassiman JJ, Decorte R: Diversity at eight polymorphic Alu insertion loci in Chinese populations shows evidence for European admixture in an ethnic minority population from northwest China. Hum Biol 2002, 74:555-568.
• [22]Iwasaki M, Kobayashi K, Suzuki H, et al.: Polymorphism of the ABO blood group genes in Han, Kazak and Uygur populations in the Silk Route of northwestern China. Tissue Antigens 2000, 56(2):136-142.
• [23]Yao YG, Kong QP, Wang CY, Zhu CL, Zhang YP: Different matrilineal contributions to genetic structure of ethnic groups in the silk road region in China. Mol Biol Evol 2004, 21:2265-2280.
• [24]Zheng YY, Xie X, Ma YT, et al.: Relationship between type 2 diabetes mellitus and a novel polymorphism C698T in C5L2in the Chinese Han population. Endocrine 2012, 41(2):296-301.
• [25]Daviglus ML, Liu K, Pirzada A, et al.: Favorable cardiovascular risk profile in middle age and health-related quality of life in older age. Arch Intern Med 2003, 163:2460-2468.
• [26]Stamler J, Stamler R, Neaton JD, et al.: Low risk-factor profile and long-term cardiovascular and non-cardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999, 282:2012-2018.
• [27]Neaton J, Wentworth D: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316,099 white men. Arch Intern Med 1992, 152:56-64.
• [28]Kaukua J, Turpeinen A, Uusitupa M, Niskanen L: Clustering of cardio-vascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking. Diabetes Obes Metab 2001, 3:17-23.
• [29]Yusuf HR, Giles WH, Croft JB, Anda RF, Casper ML: Impact of multiple risk factor profiles on determining cardiovascular disease risk. Prev Med 1998, 27:1-9.
• [30]Miller YD, Dunstan DW: The effectiveness of physical activity interventions for the treatment of overweight and obesity and type 2 diabetes. J Sci Med Sport 2004, 7:52-59.
• [31]Thomson CC, Rigotti NA: Hospital- and clinic-based smoking cessation interventions for smokers with cardiovascular disease. Prog Cardiovasc Dis 2003, 45:459-479.